Calreticulin (CALR) Mutation Molecular Detection
Test Catalog Information
Test Catalog Synonyms | |
EPIC Synonyms |
JAK2-negative myeloproliferative neoplasm Myeloproliferative disorders |
Cerner Primary Mnemonic | HLX CALR CASE |
EPIC Display Name | Calreticulin (CALR) Mutation Molecular Detection |
Allscripts (AEHR) Order Name | HLX Calreticulin Case (HLX CALR CASE) |
Sunrise Clinical Manager (SCM) Order Name | Calreticulin Gene Mutation Analysis |
EPIC Inpatient Orderable | Yes |
EPIC Outpatient Orderable | Yes |
Cerner Results | |
Clinical Info |
The most common mutation in patients with myeloproliferative neoplasms polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) is JAK2 V617F. CALR somatic mutations are seen in a large subset of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF) who lack JAK2 and MPL mutations. CALR mutations are not found in patients with PV. Patients with a mutated CALR have a higher level of platelets, lower hemoglobin, a lower rate of thrombosis and overall better outcome than patients with a JAK2 or MPL mutation. |
Specimen Type |
Blood, Bone Marrow |
Container |
Lavender Top Tube |
Collection Instructions |
Peripheral Blood or Bone marrow Container/Tube: Lavender-top (EDTA) tube Specimen: 1-3 mL peripheral blood or Bone marrow |
Transport Instructions |
room temperature or at 4C with ice cold packs |
Specimen Stability |
Specimens are stable for a week refrigerated. |
Methodology |
Polymerase Chain Reaction (PCR) Amplification/Capillary Electrophoresis |
Days Performed |
Monday through Friday TAT: 8 Calendar days |
Performing Laboratory |
Northwell Health Laboratories |
CPT |
83891 - DNA extract-purify 81219 |
PDM |
1763033 |
Desired Epic Build Calreticulin (CALR) Mutation Molecular Detection
Cerner Primary Mnemonic: | HLX CALR CASE |
PDM | 1763033 |
Informatics - Workgroup | Molpath inhouse |
Synonyms * | JAK2-negative myeloproliferative neoplasm Myeloproliferative disorders |
Display Name * | Calreticulin (CALR) Mutation Molecular Detection |
Order Entry Specimen Sources * | |
Order Entry Specimen Types |
Aspirate
|
Specimen Navigator Specimen Types | |
Specimen Navigator Specimen Sources | |
Specimen Navigator Short Name | |
Ordering info (EPIC SmartText) | The most common mutation in patients with myeloproliferative neoplasms polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) is JAK2 V617F. CALR somatic mutations are seen in a large subset of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF) who lack JAK2 and MPL mutations. CALR mutations are not found in patients with PV. Patients with a mutated CALR have a higher level of platelets, lower hemoglobin, a lower rate of thrombosis and overall better outcome than patients with a JAK2 or MPL mutation. |
IP Orderable | Yes |
OP Orderable | Yes |
AOEs * | |
AP AOEs | |
Special History | Yes |
Build Comments | |
Filter * | genetics |
Procedure Category Change | |
Cerner Results |
Current Actual EPIC Build as of 10/28/2024
Procedure Id | 115607 | ||||||||||||||||||||||||
Pdm | 1763033 | ||||||||||||||||||||||||
Order Display Name | Calreticulin (CALR) Mutation Molecular Detection | ||||||||||||||||||||||||
Procedure Name | CALRETICULIN GENE MUTATION ANALYSIS | ||||||||||||||||||||||||
Procedure Master Number | LAB11646 | ||||||||||||||||||||||||
Short Procedure Name | CALRETICULIN GENE MUTATION ANALYSIS | ||||||||||||||||||||||||
Category Code | 21.0 | ||||||||||||||||||||||||
Category Code Record Name | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||||||||||||||
Synonyms | JAK2-NEGATIVE MYELOPROLIFERATIVE NEOPLASM MYELOPROLIFERATIVE DISORDERS | ||||||||||||||||||||||||
Clinically Active | Yes | ||||||||||||||||||||||||
Orderable | Yes | ||||||||||||||||||||||||
Performable | Yes | ||||||||||||||||||||||||
Filter Genomics | Generic Genomics Procedure | ||||||||||||||||||||||||
Reference Link Url | https://labs.northwell.edu/epic/test/115607 | ||||||||||||||||||||||||
Ordering Instructions | |||||||||||||||||||||||||
Default Specimen Type | Blood | ||||||||||||||||||||||||
Specimen Type Pick List | Bone Marrow Blood | ||||||||||||||||||||||||
Specimen Type List | |||||||||||||||||||||||||
Op Specimen Type List | |||||||||||||||||||||||||
Specimen Source Pick List | Bone Marrow Aspirate Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||
Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||
Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||
Specimen Source List | |||||||||||||||||||||||||
Op Specimen Source List | |||||||||||||||||||||||||
Ip Lab Test Components For Report | HLXCALR:10 | ||||||||||||||||||||||||
Op Lab Test Components For Report | HLXCALR:10 | ||||||||||||||||||||||||
Order Questions | ["3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||
Order Questions Record Name | NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY | ||||||||||||||||||||||||
Inpatient Order Questions | ["3048500000"] | ||||||||||||||||||||||||
Inpatient Order Questions Record Name | |||||||||||||||||||||||||
Order Specific Question Override | Yes | ||||||||||||||||||||||||
Inpatient Question Override | |||||||||||||||||||||||||
Location Restrict List Ip | |||||||||||||||||||||||||
Location Restrict List Ip Record Name | |||||||||||||||||||||||||
Location Restrict List Include Ip | |||||||||||||||||||||||||
Location Restrict List Op | |||||||||||||||||||||||||
Location Restrict List Op Record Name | |||||||||||||||||||||||||
Location Restrict List Includes Op | |||||||||||||||||||||||||
Edp Amb Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||
Edp Ip Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||
Edp Ip Specimen Source | |||||||||||||||||||||||||
Edp Op Specimen Source | |||||||||||||||||||||||||
Edp Ip Specimen Type | |||||||||||||||||||||||||
Edp Op Specimen Type | |||||||||||||||||||||||||
Derived Edp Ip Buttons S | |||||||||||||||||||||||||
Derived Edp Ip Buttons T | |||||||||||||||||||||||||
Derived Edp Op Buttons S | |||||||||||||||||||||||||
Derived Edp Op Buttons T | |||||||||||||||||||||||||
Ip Orderable | 1 | ||||||||||||||||||||||||
Op Orderable | 1 | ||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||
EPIC IP AOEs
| |||||||||||||||||||||||||
EPIC Components (results) |